Stoke Therapeutics, Inc. STOK Return on invested capital
Return on invested capital at other companies
Other financials
Where this comes from
Calculated from Stoke Therapeutics, Inc.’s reported figures.
Based on trailing twelve months.
The official record: Stoke Therapeutics, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Stoke Therapeutics, Inc.'s return on invested capital.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Stoke Therapeutics, Inc.'s return on invested capital?
- Stoke Therapeutics, Inc. (STOK) reported return on invested capital of -114.4% in Q1 2026.
- What does return on invested capital mean?
- Net operating profit after tax (operating income taxed at the effective rate) divided by average invested capital (debt plus equity minus cash). Measures the after-tax return on all capital put to work in the business, independent of capital structure.